Cargando…

Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII)

BACKGROUND: There is an active debate about the role that endpoints other than overall survival (OS) should play in the drug approval process. Yet the term ‘surrogate endpoint’ implies that OS is the only critical metric for regulatory approval of cancer treatments. We systematically analyzed the re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Neon, Campone, Mario, Paddock, Silvia, Shortenhaus, Scott, Grainger, David, Zummo, Jacqueline, Thomas, Samuel, Li, Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699106/ https://www.ncbi.nlm.nih.gov/pubmed/29167693 http://dx.doi.org/10.7573/dic.212507

Ejemplares similares

CII 10070 computer
por: CERN PhotoLab
Publicado: (1971)

Lima CII Booster Eject
Publicado: (1995)

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
por: Nandakumar, Kutty Selva, et al.
Publicado: (2004)

The Bacteriophage Lambda CII Phenotypes for Complementation, Cellular Toxicity and Replication Inhibition Are Suppressed in cII-oop Constructs Expressing the Small RNA OOP
por: Rajamanickam, Karthic, et al.
Publicado: (2018)

Center for Interdisciplinary Research in Health (CIIS) National Meeting 2023
Publicado: (2023)

PACE Continuous Innovation Indicators—a novel tool to measure progress in cancer treatments
por: Paddock, Silvia, et al.
Publicado: (2015)

Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation
por: Sethi, Sanjeev, et al.
Publicado: (2018)

Proof-of-concept study: Homomorphically encrypted data can support real-time learning in personalized cancer medicine
por: Paddock, Silvia, et al.
Publicado: (2019)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

STAT1 Interacts with RXRα to Upregulate ApoCII Gene Expression in Macrophages
por: Trusca, Violeta G., et al.
Publicado: (2012)

CIINE Reflects Collagenase-Specific CII Breakdown in Cartilage Explant and Whole Body of Canine
por: Matsukawa, Satoko, et al.
Publicado: (2013)

Instability of CII is needed for efficient switching between lytic and lysogenic development in bacteriophage 186
por: Murchland, Iain M, et al.
Publicado: (2020)

Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017)

Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
por: Chabner, Bruce A.
Publicado: (2017)

Time-dependent endpoints as predictors of overall survival in multiple myeloma
por: Félix, Jorge, et al.
Publicado: (2013)

Structure of the Glycosyltransferase EryCIII in Complex with its Activating P450 Homologue EryCII
por: Moncrieffe, Martin C., et al.
Publicado: (2012)

Effect of Bizhongxiao Decotion (BZXD) on Some Cytokines in Plasma of Rats with CII-induced Rheumatoid Arthritis
por: Wang, An-yu, et al.
Publicado: (2005)

The CI Index (CII): A New Instrument to Evaluate and Foster Collaborative Partnership in Public Health
por: Salihu, Hamisu M, et al.
Publicado: (2018)

Construction of CII-Specific CAR-T to Explore the Cytokine Cascades Between Cartilage-Reactive T Cells and Chondrocytes
por: Liu, Xiaolong, et al.
Publicado: (2020)

Analysis of Infection Time Courses Shows CII Levels Determine the Frequency of Lysogeny in Phage 186
por: Hao, Nan, et al.
Publicado: (2021)

Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology
por: Sherrill, Beth, et al.
Publicado: (2012)

The implementation of the Cii Honeywell Bull disks as backup medium for the file storage of the main control computers of the ISR
por: Tausch, Lothar A, et al.
Publicado: (1981)

A postsynaptic PI3K-cII dependent signaling controller for presynaptic homeostatic plasticity
por: Hauswirth, Anna G, et al.
Publicado: (2018)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?
por: Forsythe, Anna, et al.
Publicado: (2018)

Table of Contents: Fourth International Congress of CiiEM: Health, Well-Being and Ageing in the 21st Century
Publicado: (2021)

Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints
por: Kakkis, Emil D, et al.
Publicado: (2015)

Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008–2012)
por: Bansal, Dipika, et al.
Publicado: (2015)

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer
por: Maeda, Hideki, et al.
Publicado: (2021)

Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma
por: Li, Yuan Fang, et al.
Publicado: (2022)

Guidelines for Keeping Pace with Innovation and Tech Adoption
por: Schindler, Esther
Publicado: (2016)

Determinants of the Pace of Global Innovation in Energy Technologies
por: Bettencourt, Luís M. A., et al.
Publicado: (2013)

Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar
por: Mendonca Costa, Caroline, et al.
Publicado: (2020)

Role of anchorin CII, a 31,000-mol-wt membrane protein, in the interaction of chondrocytes with type II collagen
Publicado: (1984)

The implementation of a new Operating System for the ISR Main Computers based on the Cii-Honeywell Bull disks of 10 Megabytes
por: Tausch, Lothar A
Publicado: (1983)

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
por: Fallaize, Rosalind, et al.
Publicado: (2017)

MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells
por: Ashofteh, Nooshin, et al.
Publicado: (2021)

Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
por: Gyawali, Bishal, et al.
Publicado: (2020)

For LV pacing, four is greater than two
por: Reynolds, Matthew R., et al.
Publicado: (2017)

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
por: Jackson, Richard, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_segv2nm3dv4ofbfnb4oi9ksv9t